DeepMed Research

CHA University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1999-01-01

Employees: -

Market Cap: -

Website: http://www.cha.ac.kr

Clinical Trials

Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer (GemCiNT)

Recruiting

Conditions: Locally Advanced Biliary Tract Cancers
Metastatic Biliary Tract Cancers

Interventions: Drug: Gemcitabine, Cisplatin, Nab-paclitaxel, and Tislelizumab.

First Posted Date: 2025-03-25

Last Posted Date: 2025-04-03

Lead Sponsor: CHA University

Target Recruit Count: 61

Registration Number: NCT06893380

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the Treatment of Elbow Tendinopathy

Phase 4

Not yet recruiting

Conditions: Elbow Tendinopathy

Interventions: Biological: Autologous Platelet-Rich Plasma (PRP) Injection

First Posted Date: 2025-02-07

Last Posted Date: 2025-02-07

Lead Sponsor: CHA University

Target Recruit Count: 30

Registration Number: NCT06815042

Locations: 🇰🇷
Bundang CHA Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

Recruiting

Conditions: Biliary Tract Cancer
Cholangiocarcinoma

Interventions: Drug: lenvatinib plus pembrolizumab

First Posted Date: 2024-10-18

Last Posted Date: 2024-10-18

Lead Sponsor: CHA University

Target Recruit Count: 100

Registration Number: NCT06648057

Locations: 🇰🇷
Bundang CHA Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

RCVR (Residual CardioVascular Risk) Prospective Multicenter Study

Recruiting

Conditions: Coronary Artery Disease

Interventions: Diagnostic Test: Blood Sample
Other: DICOM Dataset

First Posted Date: 2024-09-30

Last Posted Date: 2024-09-30

Lead Sponsor: CHA University

Target Recruit Count: 1000

Registration Number: NCT06619353

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study

Phase 4

Recruiting

Conditions: Acute Coronary Syndrome

Interventions: Drug: Colchicine 0.6 mg

First Posted Date: 2024-08-07

Last Posted Date: 2024-08-09

Lead Sponsor: CHA University

Target Recruit Count: 490

Registration Number: NCT06543082

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive

Phase 4

Completed

Conditions: Glaucoma
Ocular Hypertensive

Interventions: Drug: BRIDIN-plus Eye drops
Drug: Combigan Eye drops

First Posted Date: 2023-10-12

Last Posted Date: 2025-03-26

Lead Sponsor: CHA University

Target Recruit Count: 60

Registration Number: NCT06078592

Locations: 🇰🇷
Seungsoo Rho, Seoul, Seongnam, Bundang-gu, Korea, Republic of

Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients

Not Applicable

Recruiting

Conditions: Glaucoma

Interventions: Other: Nicotinamide(Mitovita)
Other: Placebo

First Posted Date: 2023-10-12

Last Posted Date: 2023-10-12

Lead Sponsor: CHA University

Target Recruit Count: 80

Registration Number: NCT06078605

Locations: 🇰🇷
CHA University Bundang Medical Center, Seongnam, Bundang-gu, Korea, Republic of

Development of the Neuroimaging Biomarker-based Prediction Model of Anxiety-related Disorders: Effect of Mindfulness-based Cognitive Therapy Using Neuroscience on the Brain

Not Applicable

Not yet recruiting

Conditions: Anxiety Depression

Interventions: Behavioral: Mindfulness-based cognitive therapy using neuroscience (NMBCT)

First Posted Date: 2023-06-22

Last Posted Date: 2023-08-25

Lead Sponsor: CHA University

Target Recruit Count: 64

Registration Number: NCT05911412

Treatment Efficacy of Mindfulness-based Cognitive Therapy for Distress in Advanced Cancer Patients

Not Applicable

Conditions: Distress, Emotional
Cancer Pain
Psychiatric or Mood Diseases or Conditions
Cancer
Therapy-Associated Cancer
Psychological Distress

Interventions: Behavioral: Mindfulness-Based Cognitive-behavioral Therapy for Distress

First Posted Date: 2023-03-14

Last Posted Date: 2023-04-05

Lead Sponsor: CHA University

Target Recruit Count: 40

Registration Number: NCT05768256

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Kyeonggi-do, Korea, Republic of

Clinical Feasibility of Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in Locally Advanced Cholangiocarcinoma

Recruiting

Conditions: Locally Advanced Cholangiocarcinoma

First Posted Date: 2023-01-10

Last Posted Date: 2024-02-07

Lead Sponsor: CHA University

Target Recruit Count: 100

Registration Number: NCT05677217

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy